Home
June 2008 July 2008 August 2008
Su Mo Tu We Th Fr Sa
Week 27 1 2 3 4 5
Week 28 6 7 8 9 10 11 12
Week 29 13 14 15 16 17 18 19
Week 30 20 21 22 23 24 25 26
Week 31 27 28 29 30 31

Bladder Cancer Diagnosis & Monitoring Center - Current Clinical Trials Show Comments PDF Print E-mail
  
Bladder Cancer Diagnosis and Monitoring Center

Current Clinical Trials

NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-Refractory Patients With Non-Muscle Invasive Bladder Cancer

Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy

Hexvix Cystoscopy for Detection of Bladder Cancer

Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Detection of Bladder Cancer Microsatellite Analysis (MSA) of Urinary Sediment

Survivin Urine mRNA Assay Risk of Bladder Cancer Study

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 1
PoorBest


 
Visitor Ratings:
No Affiliation:
5 (1 votes)